MetaADEDB 2.0 @ LMMD
Doxazosin
(VJECBOKJABCYMF-UHFFFAOYSA-N)
Structure
SMILES
CS(=O)(=O)O.COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2
Molecular Formula:
C24H29N5O8S
Molecular Weight:
547.581
Log P:
2.8867
Hydrogen Bond Acceptor:
13
Hydrogen Bond Donor:
2
TPSA:
175.02
CAS Number(s):
77883-43-3
Synonym(s)
1.
Doxazosin
2.
Doxazosin Mesylate
3.
1 (4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-((2,3-dihydro-1,4-benzodioxin-2-yl)carbonyl)piperazine
4.
Alfamedin
5.
Apo-Doxazosin
6.
Cardular
7.
Cardura
8.
Carduran
9.
Carduran Neo
10.
Diblocin
11.
Doxa-Puren
12.
DoxaUro
13.
Doxacor
14.
Doxagamma
15.
Doxamax
16.
Doxatensa
17.
Doxazomerck
18.
Doxazosin AL
19.
Doxazosin AZU
20.
Doxazosin Apogepha
21.
Doxazosin Heumann
22.
Doxazosin Klast
23.
Doxazosin Monohydrochloride
24.
Doxazosin Stada
25.
Doxazosin Von Ct
26.
Doxazosin beta
27.
Doxazosin findusFit
28.
Doxazosin-Wolff
29.
Doxazosin-ratiopharm
30.
Doxazosina Alter
31.
Doxazosina Cinfa
32.
Doxazosina Combino Pharm
33.
Doxazosina Geminis
34.
Doxazosina Normon
35.
Doxazosina Pharmagenus
36.
Doxazosina Ratiopharm
37.
Doxazosina Ur
38.
Gen-Doxazosin
39.
Jutalar
40.
MTW-Doxazosin
41.
Novo-Doxazosin
42.
Progandol Neo
43.
UK-33274
44.
Uriduct
45.
Zoxan
46.
ratio-Doxazosin
47.
Apo Doxazosin
48.
Ct, Doxazosin Von
49.
Doxa Puren
50.
Doxazosin Wolff
51.
Doxazosin ratiopharm
52.
Gen Doxazosin
53.
MTW Doxazosin
54.
Mesylate, Doxazosin
55.
Monohydrochloride, Doxazosin
56.
Neo, Carduran
57.
Novo Doxazosin
58.
Ratiopharm, Doxazosina
59.
UK 33274
60.
UK33274
61.
Von Ct, Doxazosin
62.
ratio Doxazosin
External Link(s)
MeSHD017292
PubChem Compound25137856
62978
135998657
ChEBI4709
CHEMBLCHEMBL1200561
KEGGdr:D00608
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 63
Canada Vigilance: 1
Canada Vigilance
US FAERS
2DizzinessFAERS: 53US FAERS
3Floppy iris syndromeFAERS: 37US FAERS
4HypotensionFAERS: 31US FAERS
5SyncopeFAERS: 31US FAERS
6HeadacheFAERS: 30US FAERS
7FatigueFAERS: 27
Canada Vigilance: 2
Canada Vigilance
US FAERS
8NauseaFAERS: 24
Canada Vigilance: 2
Canada Vigilance
US FAERS
9MalaiseFAERS: 19US FAERS
10DysuriaFAERS: 17US FAERS
11Urinary IncontinenceFAERS: 15US FAERS
12VomitingFAERS: 15US FAERS
13AstheniaFAERS: 14US FAERS
14Pharmaceutical product complaintFAERS: 13US FAERS
15Sinus TachycardiaFAERS: 12US FAERS
16Cerebrovascular accidentFAERS: 11US FAERS
17PneumoniaFAERS: 11US FAERS
18PresyncopeFAERS: 11US FAERS
19MyalgiaFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
20Myocardial InfarctionFAERS: 10US FAERS
21PainFAERS: 10US FAERS
22ProstatectomyFAERS: 10US FAERS
23Urinary RetentionFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
24Visual ImpairmentFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
25AnxietyFAERS: 9US FAERS
26ArthralgiaFAERS: 9US FAERS
27Blood pressure inadequately controlledFAERS: 9US FAERS
28IridoceleFAERS: 9US FAERS
29RhabdomyolysisFAERS: 9US FAERS
30CataractFAERS: 8US FAERS
31SomnolenceFAERS: 8US FAERS
32TachycardiaFAERS: 8US FAERS
33UrticariaFAERS: 8US FAERS
34Accidental drug intake by childFAERS: 7US FAERS
35Benign Prostatic HyperplasiaFAERS: 7US FAERS
36Cardiac ArrestFAERS: 7US FAERS
37HypersensitivityFAERS: 7US FAERS
38PalpitationsFAERS: 7US FAERS
39Abdominal PainFAERS: 6US FAERS
40Accidental exposureFAERS: 6US FAERS
41Back PainFAERS: 6US FAERS
42BronchitisFAERS: 6US FAERS
43Cerebral InfarctionFAERS: 6US FAERS
44ChokingFAERS: 6US FAERS
45Drug dispensing errorFAERS: 6US FAERS
46EpistaxisFAERS: 6US FAERS
47LethargyFAERS: 6US FAERS
48Neck PainFAERS: 6US FAERS
49No adverse eventFAERS: 6US FAERS
50Procedural complicationFAERS: 6US FAERS
51Product quality issueFAERS: 6US FAERS
52Product use in unapproved indicationFAERS: 6US FAERS
53PruritusFAERS: 6US FAERS
54Suicide attemptFAERS: 6US FAERS
55TinnitusFAERS: 6US FAERS
56Aortic AneurysmFAERS: 5US FAERS
57Blood creatine phosphokinase increasedFAERS: 5US FAERS
58Blood creatinine increasedFAERS: 5US FAERS
59Chest PainFAERS: 5US FAERS
60DeafnessFAERS: 5US FAERS
61Depressed Level of ConsciousnessFAERS: 5US FAERS
62Feeling abnormalFAERS: 5US FAERS
63InfarctionFAERS: 5US FAERS
64Medication ErrorFAERS: 5US FAERS
65NephrolithiasisFAERS: 5US FAERS
66Respiratory FailureFAERS: 5US FAERS
67ThrombosisFAERS: 5US FAERS
68TremorFAERS: 5US FAERS
69Urinary tract infectionFAERS: 5US FAERS
70VertigoFAERS: 5US FAERS
71ArthritisFAERS: 4US FAERS
72Blood count abnormalFAERS: 4US FAERS
73BradycardiaFAERS: 4US FAERS
74Cataract operationFAERS: 4US FAERS
75Diabetes MellitusFAERS: 4US FAERS
76InfluenzaFAERS: 4US FAERS
77NocturiaFAERS: 4US FAERS
78OverdoseFAERS: 4US FAERS
79Product substitution issueFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
80Unevaluable eventFAERS: 4US FAERS
81AbasiaFAERS: 3US FAERS
82AgitationFAERS: 3US FAERS
83AlopeciaFAERS: 3US FAERS
84Anaphylactic shockFAERS: 3US FAERS
85AsthmaFAERS: 3US FAERS
86AuraFAERS: 3US FAERS
87Blood glucose decreasedFAERS: 3US FAERS
88Chest discomfortFAERS: 3US FAERS
89CystitisFAERS: 3US FAERS
90DisorientationFAERS: 3US FAERS
91DiverticulitisFAERS: 3US FAERS
92Drug administration errorFAERS: 3US FAERS
93DysarthriaFAERS: 3US FAERS
94EnuresisFAERS: 3US FAERS
95Erectile dysfunctionFAERS: 3US FAERS
96ErythemaFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
97Eye irritationFAERS: 3US FAERS
98FlatulenceFAERS: 3US FAERS
99HerniaFAERS: 3US FAERS
100HypersomniaFAERS: 3US FAERS
101Hypertensive crisisFAERS: 3US FAERS
102IncontinenceFAERS: 3US FAERS
103InfectionFAERS: 3US FAERS
104Joint swellingFAERS: 3US FAERS
105Lip swellingFAERS: 3US FAERS
106Medication residueFAERS: 3US FAERS
107NoduleFAERS: 3US FAERS
108PancreatitisFAERS: 3US FAERS
109PancytopeniaFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
110Product use issueFAERS: 3US FAERS
111ShockFAERS: 3US FAERS
112Sinus bradycardiaFAERS: 3US FAERS
113ThrombocytopeniaFAERS: 3
Canada Vigilance: 3
Canada Vigilance
US FAERS
114Weight decreasedFAERS: 3US FAERS
115nervous system disorderFAERS: 3US FAERS
116prostatitisFAERS: 3US FAERS
117Abdominal discomfortFAERS: 2US FAERS
118Alanine Aminotransferase IncreasedFAERS: 2US FAERS
119Anaphylactoid ReactionFAERS: 2US FAERS
120AngioedemaFAERS: 2US FAERS
121Ankle FractureFAERS: 2US FAERS
122AnorexiaFAERS: 2US FAERS
123ArthropathyFAERS: 2US FAERS
124Aspartate Aminotransferase IncreasedFAERS: 2US FAERS
125AsphyxiaFAERS: 2US FAERS
126BlindnessFAERS: 2US FAERS
127Blood pressure fluctuationFAERS: 2US FAERS
128CardiomegalyFAERS: 2US FAERS
129Cataract operation complicationFAERS: 2US FAERS
130Cold sweatFAERS: 2US FAERS
131Coronary Artery DiseaseFAERS: 2US FAERS
132CystFAERS: 2US FAERS
133Death of childFAERS: 2US FAERS
134DehydrationFAERS: 2US FAERS
135DementiaFAERS: 2US FAERS
136Depressed moodFAERS: 2US FAERS
137Diabetes InsipidusFAERS: 2US FAERS
138DroolingFAERS: 2US FAERS
139GastritisFAERS: 2US FAERS
140GoutFAERS: 2US FAERS
141HepatitisFAERS: 2US FAERS
142HypoxiaFAERS: 2US FAERS
143Intentional product misuseFAERS: 2US FAERS
144Memory impairmentFAERS: 2US FAERS
145Mental impairmentFAERS: 2US FAERS
146Nerve injuryFAERS: 2US FAERS
147NervousnessFAERS: 2US FAERS
148ObesityFAERS: 2US FAERS
149Oropharyngeal painFAERS: 2US FAERS
150Peripheral swellingFAERS: 2US FAERS
151PolyneuropathyFAERS: 2US FAERS
152Post procedural complicationFAERS: 2US FAERS
153Prostate examination abnormalFAERS: 2US FAERS
154Renal painFAERS: 2US FAERS
155Respiratory DepressionFAERS: 2US FAERS
156RetchingFAERS: 2US FAERS
157Retrograde ejaculationFAERS: 2US FAERS
158RhinitisFAERS: 2US FAERS
159Semen analysis abnormalFAERS: 2US FAERS
160Sexual DysfunctionFAERS: 2US FAERS
161Sinus ArrhythmiaFAERS: 2US FAERS
162Sputum retentionFAERS: 2US FAERS
163Stool analysis abnormalFAERS: 2US FAERS
164SwellingFAERS: 2US FAERS
165Therapeutic response unexpected with drug substitutionFAERS: 2US FAERS
166White blood cell count decreasedFAERS: 2US FAERS
167Wrong technique in drug usage processFAERS: 2US FAERS
168Activities of daily living impairedFAERS: 1US FAERS
169Acute Coronary SyndromeFAERS: 1US FAERS
170Acute kidney injuryFAERS: 1US FAERS
171Acute myocardial infarctionFAERS: 1US FAERS
172AgranulocytosisFAERS: 1US FAERS
173Angina PectorisFAERS: 1US FAERS
174Antinuclear antibody increasedFAERS: 1US FAERS
175AnuriaFAERS: 1US FAERS
176AppendicitisFAERS: 1US FAERS
177AtaxiaFAERS: 1US FAERS
178Atrial FibrillationFAERS: 1US FAERS
179Atrioventricular BlockFAERS: 1US FAERS
180Benign neoplasm of thyroid glandFAERS: 1US FAERS
181Bladder discomfortFAERS: 1US FAERS
182Bladder painFAERS: 1US FAERS
183Blood cholesterol increasedFAERS: 1US FAERS
184Blood glucose fluctuationFAERS: 1US FAERS
185Blood glucose increasedFAERS: 1US FAERS
186Blood lactate dehydrogenase increasedFAERS: 1US FAERS
187Blood potassium increasedFAERS: 1US FAERS
188Blood pressure orthostatic abnormalFAERS: 1US FAERS
189Blood urine presentFAERS: 1US FAERS
190Brain natriuretic peptide increasedFAERS: 1US FAERS
191Brain scan abnormalFAERS: 1US FAERS
192BronchospasmFAERS: 1US FAERS
193Cardiac assistance device userFAERS: 1US FAERS
194Choking sensationFAERS: 1US FAERS
195CholelithiasisFAERS: 1US FAERS
196ChromaturiaFAERS: 1US FAERS
197Circumstance or information capable of leading to medication errorFAERS: 1US FAERS
198ColectomyFAERS: 1US FAERS
199Colonoscopy abnormalFAERS: 1US FAERS
200ConstipationFAERS: 1US FAERS
201CryingFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
202Deep Vein ThrombosisFAERS: 1US FAERS
203DependenceFAERS: 1US FAERS
204Dermatitis HerpetiformisFAERS: 1US FAERS
205DisabilityFAERS: 1US FAERS
206DiscomfortFAERS: 1US FAERS
207Drug abuseFAERS: 1US FAERS
208Drug exposure during pregnancyFAERS: 1US FAERS
209Drug prescribing errorFAERS: 1US FAERS
210Drug screen false positiveFAERS: 1US FAERS
211Drug toxicityFAERS: 1US FAERS
212DysgeusiaFAERS: 1US FAERS
213DysgraphiaFAERS: 1US FAERS
214DyspepsiaFAERS: 1US FAERS
215DysphoniaFAERS: 1US FAERS
216DysplasiaFAERS: 1US FAERS
217Ear discomfortFAERS: 1US FAERS
218Expired drug administeredFAERS: 1US FAERS
219Eye painFAERS: 1US FAERS
220Feeling ColdFAERS: 1US FAERS
221Feeling of body temperature changeFAERS: 1US FAERS
222FibromyalgiaFAERS: 1US FAERS
223FlushingFAERS: 1US FAERS
224Foreign body traumaFAERS: 1US FAERS
225Gamma-Glutamyltransferase IncreasedFAERS: 1US FAERS
226Gastric infectionFAERS: 1US FAERS
227Gastric ulcerFAERS: 1US FAERS
228GastroenteritisFAERS: 1US FAERS
229Gastrointestinal carcinomaFAERS: 1US FAERS
230Gastrointestinal tract adenomaFAERS: 1US FAERS
231Hallucinations, mixedFAERS: 1US FAERS
232Head discomfortFAERS: 1US FAERS
233Heart sounds abnormalFAERS: 1US FAERS
234Hepatojugular refluxFAERS: 1US FAERS
235Hypoglossal nerve paresisFAERS: 1US FAERS
236Iatrogenic injuryFAERS: 1US FAERS
237IleusFAERS: 1US FAERS
238Increased tendency to bruiseFAERS: 1US FAERS
239IndurationFAERS: 1US FAERS
240InflammationFAERS: 1US FAERS
241Intentional drug misuseFAERS: 1US FAERS
242Intentional product use issueFAERS: 1US FAERS
243Intestinal ObstructionFAERS: 1US FAERS
244Iris injuryFAERS: 1US FAERS
245Labile blood pressureFAERS: 1US FAERS
246LaryngitisFAERS: 1US FAERS
247Limb injuryFAERS: 1US FAERS
248Livedo ReticularisFAERS: 1US FAERS
249Low density lipoprotein increasedFAERS: 1US FAERS
250Male Orgasmic DisorderFAERS: 1US FAERS
251Medication residue presentFAERS: 1US FAERS
252Multi-organ disorderFAERS: 1US FAERS
253Multiple SclerosisFAERS: 1US FAERS
254Musculoskeletal chest painFAERS: 1US FAERS
255Musculoskeletal stiffnessFAERS: 1US FAERS
256MyopathyFAERS: 1US FAERS
257MyositisFAERS: 1US FAERS
258NasopharyngitisFAERS: 1US FAERS
259Night sweatsFAERS: 1US FAERS
260Obesity surgeryFAERS: 1US FAERS
261OliguriaFAERS: 1US FAERS
262OnychalgiaFAERS: 1US FAERS
263Oropharyngeal blisteringFAERS: 1US FAERS
264OsteoporosisFAERS: 1US FAERS
265Palmar erythemaFAERS: 1US FAERS
266PapuleFAERS: 1US FAERS
267PertussisFAERS: 1US FAERS
268PetechiaeFAERS: 1US FAERS
269PharyngitisFAERS: 1US FAERS
270Pharyngolaryngeal PainFAERS: 1US FAERS
271Poor peripheral circulationFAERS: 1US FAERS
272Pre-EclampsiaFAERS: 1US FAERS
273Pre-existing condition improvedFAERS: 1US FAERS
274Prescribed overdoseFAERS: 1US FAERS
275PriapismFAERS: 1US FAERS
276Procedural hypotensionFAERS: 1US FAERS
277Product contaminationFAERS: 1US FAERS
278Product counterfeitFAERS: 1US FAERS
279Product label issueFAERS: 1US FAERS
280Product measured potency issueFAERS: 1US FAERS
281Productive CoughFAERS: 1US FAERS
282Prothrombin level decreasedFAERS: 1US FAERS
283Pulmonary EmbolismFAERS: 1US FAERS
284PurpuraFAERS: 1US FAERS
285PylorospasmFAERS: 1US FAERS
286Renal Cell CarcinomaFAERS: 1US FAERS
287Rheumatoid ArthritisFAERS: 1US FAERS
288Rheumatoid factor increasedFAERS: 1US FAERS
289Sense of oppressionFAERS: 1US FAERS
290SinusitisFAERS: 1US FAERS
291Skin UlcerFAERS: 1US FAERS
292Sleep ParalysisFAERS: 1US FAERS
293SneezingFAERS: 1US FAERS
294SomnambulismFAERS: 1US FAERS
295StrabismusFAERS: 1US FAERS
296TenosynovitisFAERS: 1US FAERS
297Therapeutic response unexpectedFAERS: 1US FAERS
298Therapy non-responderFAERS: 1US FAERS
299ThirstFAERS: 1US FAERS
300Throat irritationFAERS: 1US FAERS
301Tongue discomfortFAERS: 1US FAERS
302Tooth LossFAERS: 1US FAERS
303TuberculosisFAERS: 1US FAERS
304Urethral StenosisFAERS: 1US FAERS
305Urine flow decreasedFAERS: 1US FAERS
306Vascular stenosisFAERS: 1US FAERS
307Venous ThrombosisFAERS: 1US FAERS
308Ventricular FibrillationFAERS: 1US FAERS
309Visual disturbanceFAERS: 1US FAERS
310WheezingFAERS: 1US FAERS
311Wound infection bacterialFAERS: 1US FAERS
312Wrong drug administeredFAERS: 1US FAERS
313Bipolar I disorderCanada Vigilance: 1Canada Vigilance
314Blood iron decreasedCanada Vigilance: 1Canada Vigilance
315LeukopeniaCanada Vigilance: 2Canada Vigilance
316MYELODYSPLASTIC SYNDROMECanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.